权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Oxidative Stress and Atrial Fibrillation

氧化应激和心房颤动

基本信息

批准号：
6743718
负责人：
David R Van Wagoner
金额：
$ 35.69万
依托单位：
CLEVELAND CLINIC LERNER COM-CWRU
依托单位国家：
美国
项目类别：
财政年份：
2001
资助国家：
美国
起止时间：
2001-06-10 至 2006-04-30
项目状态：
已结题

项目摘要

More than two million Americans suffer from various forms of atrial fibrillation (AF). AF is a major cause of stroke and an independent risk factor for mortality. Following initiation, AF tends to self-perpetuate, due in part to electrophysiological remodeling of the atria. The high rate activity of the fibrillating atria has multiple electrophysiological, metabolic, and hemodynamic consequences. AF increases atrial oxygen consumption 2-3 fold, and increases the availability of reactive oxygen species (oxidative stress). In post-cardiac surgery patients the increase in oxidative stress is striking, and one-third of these patients develop post- operative AF. The goal of this application is to determine the relationship between oxidative stress and the electrophysiological remodeling that occurs during AF. Oxidative stress modulates the activity of several ion channels (Ca, K, and ryanodine receptor) important for normal atrial function. In preliminary studies, we have demonstrated that rapid pacing of canine atria results in increased oxidative injury, and that treating patients with vitamin C (an antioxidant) can decrease the incidence of post-operative AF. Thus, we propose that increased oxidative stress is a key link between the major risk factors for the development of AF, and that the electrophysiological remodeling accompanying the onset of atrial fibrillation is the result of oxidative stress. To test our hypothesis, parallel studies will be performed in patients and in a rapidly paced canine model of AF. The aims of this study are: 1) to determine the impact of oxidative stress on action potentials, Ca, K currents, and shortening in isolated atrial myocytes; 2) to assess the oxidative injury in atrial tissue using biochemical and immunohistochemical techniques, and to correlate this with in vivo electrophysiological properties; 3) to correlate plasma levels of oxidative stress markers and anti-oxidant capacity with electrophysiological changes in vivo; 4) to prospectively evaluate antioxidant therapies, with respect to their capacity to decrease levels of markers of oxidative stress and attenuate the electrophysiological remodeling that occurs in fibrillating canine atria; and finally, to directly evaluate the impact of vitamin C on the incidence of post-operative AF in patients. Successful therapies should prevent oxidative Injury, blunting the reduction in atrial effective refractory period that accompanies the onset of AF, minimizing its perpetuation, and facilitating Its termination. We anticipate that these early interventions will prove to be the most effective approach to the long term treatment and prevention of AF.

200多万美国人患有各种形式的房颤(房颤)。房颤是中风的主要原因，也是死亡的独立危险因素。房颤发生后，房颤趋于自我延续，部分原因是房颤的电生理重构。心房纤颤的高频率活动具有多种电生理、代谢和血流动力学后果。房颤使心房耗氧量增加2-3倍，并增加了活性氧物种(氧化应激)的利用率。在心脏手术后的患者中，氧化应激的增加是惊人的，其中三分之一的患者会在术后发生房颤。这项应用的目的是确定氧化应激与房颤期间发生的电生理重构之间的关系。氧化应激调节对正常心房功能至关重要的几种离子通道(钙、钾和兰尼定受体)的活性。在初步研究中，我们已经证明了犬心房快速起搏会导致氧化损伤的增加，并且患者使用维生素C(一种抗氧化剂)可以减少术后房颤的发生率。因此，我们认为，氧化应激增加是房颤发生的主要危险因素之间的关键联系，而伴随着房颤发作的电生理重构是氧化应激的结果。为了验证我们的假设，我们将在患者和快节奏的房颤犬模型中进行平行研究。本研究的目的是：1)确定氧化应激对分离的心房肌细胞动作电位、钙、钾电流和缩短的影响；2)利用生化和免疫组织化学技术评估心房组织的氧化损伤，并将其与体内电生理特性相关联；3)将血浆氧化应激标志物和抗氧化能力水平与体内电生理变化相关联；4)前瞻性评价抗氧化剂治疗对降低氧化应激标志物水平和减轻纤化犬心房电生理重构的能力；最后，直接评价维生素C对患者术后房颤发生率的影响。成功的治疗应该预防氧化损伤，钝化伴随房颤发生的心房有效不应期的缩短，最大限度地减少房颤的持续，并促进其终止。我们预计，这些早期干预将被证明是长期治疗和预防房颤的最有效方法。